Abstract: The present application pertains to family of new crystalline molecular sieves designated SSZ-92. Molecular sieve SSZ-92 is structurally similar to sieves falling within the ZSM-48 family of molecular sieves and is characterized as having magnesium.

Abstract: A web based finance system allows users to refinance past eligible purchasing transactions. The system can include a system server(s) which is in communication through a network with client computing devices associated with customers. The server can receive customer information and determine a refinancing value range based upon the user has a bank account and/or credit risk rating information. The server can identify prior eligible credit card purchases for refinancing and the customer can select one or more purchases for refinancing and the refinancing loan terms.

Abstract: The present application pertains to family of new crystalline molecular sieves designated SSZ-93. Molecular sieve SSZ-93 is structurally similar to sieves falling within the MTT structure type such as SSZ-32x, SSZ-32, ZSM-23, EU-13, ISI-4, and KZ-1 family of molecular sieves. SSZ-93 is characterized as having magnesium.

Abstract: Described herein is a base oil synthesis via ionic catalyst oligomerization further utilizing a hydrophobic process for removing an ionic catalyst from a reaction mixture with a silica gel composition, specifically a reaction mixture comprising an oligomerization reaction to produce PAO utilizing an ionic catalyst wherein the ionic catalyst is removed post reaction.

Abstract: Techniques and architecture for determining compliance of a network with respect to a network design solution. The techniques may include determining a role for each network device of a network that comprises multiple network devices and determining one or more policies related to each network device with respect to other network devices of the network. The techniques may further include based at least in part on the roles for each network device and the one or more policies, determining a level of compliance of a configuration of the network with respect to a network design solution. Based at least in part on the level of compliance, a remedial action may be performed. In configurations, a machine learning model may be used.

Abstract: Systems and methods are described to render a Live Avatar View third-person view as an overlay of a first person Spectator View, as mirrored from a Virtual Reality headset, in a Dual Perspective View. In some embodiments, a clinician tablet may display Dual Perspective View with a full screen Spectator View, to maximize visibility, and render a translucent avatar from Live Avatar View (LAV) to overlay the Spectator View for simultaneous visibility during a therapy session. Spectator View may be critical to monitor for therapy guidance and an LAV conveys valuable movement and safety data. A translucent avatar overlay and activity cues allows monitoring the avatar from Live Avatar View in a way that would not block the Spectator View or occlude other body parts potentially hidden.

Abstract: Described herein is a base oil synthesis via ionic catalyst oligomerization further utilizing a hydrophobic process for removing an ionic catalyst from a reaction mixture with a silica gel composition, specifically a reaction mixture comprising an oligomerization reaction to produce PAO utilizing an ionic catalyst wherein the ionic catalyst is removed post reaction.

Abstract: Techniques and architecture for determining compliance of a network with respect to a network design solution. The techniques may include determining a role for each network device of a network that comprises multiple network devices and determining one or more policies related to each network device with respect to other network devices of the network. The techniques may further include based at least in part on the roles for each network device and the one or more policies, determining a level of compliance of a configuration of the network with respect to a network design solution. Based at least in part on the level of compliance, a remedial action may be performed. In configurations, a machine learning model may be used.

Abstract: In one aspect, the present invention is concerned with a treatment where it is desired that an active agent is designed to be released immediately following administration and again at a time point some time after administration of the active agent. The present invention is particularly suited to administering an agent which may be released before sleep and whilst a subject is sleeping. As well as treating certain conditions by a particular regime, the invention also provides novel formulations for an immediate, followed by a delayed release of drug.

Abstract: A novel synthetic crystalline aluminogermanosilicate molecular sieve material, designated SSZ-114, is provided. SSZ-114 can be synthesized by treating an aluminogermanosilicate molecular sieve of CTH framework topology with water or an aqueous solution of a mineral acid under conditions sufficient to degermanate at least a portion of aluminogermanosilicate molecular sieve to form a degermanated molecular sieve and calcining the degermanated molecular sieve under conditions sufficient to convert the degermanated molecular sieve to SSZ-114. Molecular sieve SSZ-114 may be used in organic compound conversion reactions and/or sorptive processes.

Abstract: An aluminosilicate molecular sieve of STW framework type, designated herein as SSZ-110, and having a molar ratio of SiO2/Al2O3 of less than 100, is provided. SSZ-110 may be synthesized using an organic structure directing agent selected from one or more of 1,4-bis(2,3-dimethyl-1H-imidazolium)butane dications, 1,5-bis(2,3-dimethyl-1H-imidazolium)pentane dications, and 1,6-bis(2,3-dimethyl-1H-imidazolium)hexane dications. SSZ-110 may be used in organic compound conversion reactions and sorptive processes.

Abstract: An aluminosilicate molecular sieve of STW framework type, designated herein as SSZ-110, and having a molar ratio of SiO2/Al2O3 of less than 100, is provided. SSZ-110 may be synthesized using an organic structure directing agent selected from one or more of 1,4-bis(2,3-dimethyl-1H-imidazolium)butane dications, 1,5-bis(2,3-dimethyl-1H-imidazolium)pentane dications, and 1,6-bis(2,3-dimethyl-1H-imidazolium)hexane dications. SSZ-110 may be used in organic compound conversion reactions and sorptive processes.

Abstract: An aluminosilicate molecular sieve of STW framework type, designated herein as SSZ-110, and having a molar ratio of SiO2/Al2O3 of less than 100, is provided. SSZ-110 may be synthesized using an organic structure directing agent selected from one or more of 1,4-bis(2,3-dimethyl-1H-imidazolium)butane dications, 1,5-bis(2,3-dimethyl-1H-imidazolium)pentane dications, and 1,6-bis(2,3-dimethyl-1H-imidazolium)hexane dications. SSZ-110 may be used in organic compound conversion reactions and sorptive processes.

Abstract: In one aspect, the present invention is concerned with a treatment where it is desired that an active agent is designed to be released immediately following administration and again at a time point some time after administration of the active agent. The present invention is particularly suited to administering an agent which may be released before sleep and whilst a subject is sleeping. As well as treating certain conditions by a particular regime, the invention also provides novel formulations for an immediate, followed by a delayed release of drug.

Abstract: A method is disclosed for synthesizing zincoaluminosilicate molecular sieve SSZ-41 having high aluminum content from a combined source of silicon oxide and aluminum oxide selected from one or more a FAU framework type zeolite and a colloidal aluminosilicate.

Abstract: In one aspect, the present invention is concerned with a treatment where it is desired that an active agent is designed to be released immediately following administration and again at a time point some time after administration of the active agent. The present invention is particularly suited to administering an agent which may be released before sleep and while a subject is sleeping. As well as treating certain conditions by a particular regime, the invention also provides novel formulations for an immediate, followed by a delayed release of drug.

Abstract: An integrated system for monitoring a chemical concentration in an ionic liquid, comprising: a. an online FTIR instrument with an ATR window; b. a sample conditioning station that removes light hydrocarbons and produces a degassed ionic liquid that is analyzed by FTIR; and c. a solvent flushing system that flows solvent across the ATR window. Also, a process for monitoring the chemical concentration, comprising: a. degassing the ionic liquid in the sample conditioning station; b. passing the degassed ionic liquid over an ATR window; c. periodically redirecting a flow of the degassed ionic liquid via a bypass line or an on-off valve that isolates the ATR window from the process unit that elutes the ionic liquid; and d. flowing a solvent and a purging gas over the ATR window during the periodically redirecting step c); and e. resuming the passing of the degassed ionic liquid over the ATR window.

Abstract: An integrated system for monitoring a chemical concentration in an ionic liquid, comprising: a. an online FTIR instrument with an ATR window; b. a sample conditioning station that removes light hydrocarbons and produces a degassed ionic liquid that is analyzed by FTIR; and c. a solvent flushing system that flows solvent across the ATR window. Also, a process for monitoring the chemical concentration, comprising: a. degassing the ionic liquid in the sample conditioning station; b. passing the degassed ionic liquid over an ATR window; c. periodically redirecting a flow of the degassed ionic liquid via a bypass line or an on-off valve that isolates the ATR window from the process unit that elutes the ionic liquid; and d. flowing a solvent and a purging gas over the ATR window during the periodically redirecting step c); and e. resuming the passing of the degassed ionic liquid over the ATR window.

Abstract: A process has been developed for preparing a Fischer-Tropsch catalyst precursor and a Fischer-Tropsch catalyst made from the precursor. The process includes preparing a catalyst precursor by contacting a boehmite material with a stabilizer containing vanadium-phosphorus. The boehmite material includes two or more different crystalline boehmites having the same average crystallite size to the nearest whole nanometer and having differing properties selected from surface area, pore volume, density and combinations thereof. The boehmite material is subjected to at least one heat treatment at a temperature of at least 500° C., either before or after the contacting step to obtain a stabilized catalyst support having a pore volume of at least 0.3 cc/g. A catalytic metal or a compound containing cobalt is applied to the stabilized catalyst support to form the catalyst precursor. Finally, the catalyst precursor is reduced to activate the catalyst precursor to obtain the Fischer Tropsch catalyst.

Abstract: A method is disclosed for synthesizing zincoaluminosilicate molecular sieve SSZ-41 having high aluminum content from a combined source of silicon oxide and aluminum oxide selected from one or more a FAU framework type zeolite and a colloidal aluminosilicate.